{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:08:49Z","timestamp":1792177729507,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T00:00:00Z","timestamp":1505865600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s00115-017-0427-7","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T12:07:27Z","timestamp":1505909247000},"page":"1385-1394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Epilepsie \u2013 neue Diagnostik, alte Medikamente?","Epilepsy\u2014new diagnostic tools, old drugs?"],"prefix":"10.1007","volume":"88","author":[{"given":"M.","family":"Tacke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gerstl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Roser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"R\u00e9mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Borggraefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,20]]},"reference":[{"issue":"1","key":"427_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1528-1167.2011.03346.x","volume":"53","author":"G Bechi","year":"2012","unstructured":"Bechi G, Scalmani P, Schiavon E et\u00a0al (2012) Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations. Epilepsia 53(1):87\u2013100. \n                        https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03346.x","journal-title":"Epilepsia"},{"issue":"7","key":"427_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.braindev.2009.02.008","volume":"31","author":"K Brockmann","year":"2009","unstructured":"Brockmann K (2009) The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 31(7):545\u2013552. \n                        https:\/\/doi.org\/10.1016\/j.braindev.2009.02.008","journal-title":"Brain Dev"},{"issue":"5","key":"427_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.seizure.2011.01.004","volume":"20","author":"MJ Brodie","year":"2011","unstructured":"Brodie MJ, Sills GJ (2011) Combining antiepileptic drugs\u2014rational polytherapy? Seizure 20(5):369\u2013375. \n                        https:\/\/doi.org\/10.1016\/j.seizure.2011.01.004","journal-title":"Seizure"},{"key":"427_CR4","volume-title":"Jasper\u2019s basic mechanisms of the epilepsies","author":"WA Catterall","year":"2012","unstructured":"Catterall WA (2012) Sodium channel mutations and epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV (Hrsg) Jasper\u2019s basic mechanisms of the epilepsies. Oxford University Press, Bethesda"},{"issue":"9242","key":"427_CR5","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","volume":"356","author":"C Chiron","year":"2000","unstructured":"Chiron C, Marchand MC, Tran A et al (2000) Stiripentol in severe myoclonic epilepsy in infancy: a\u00a0randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 356(9242):1638\u20131642. \n                        https:\/\/doi.org\/10.1016\/S0140-6736(00)03157-3","journal-title":"Lancet"},{"issue":"21","key":"427_CR6","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","volume":"376","author":"O Devinsky","year":"2017","unstructured":"Devinsky O, Cross JH, Laux L et al (2017) Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. N\u00a0Engl J Med 376(21):2011\u20132020. \n                        https:\/\/doi.org\/10.1056\/NEJMoa1611618","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"427_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","volume":"52","author":"C Dravet","year":"2011","unstructured":"Dravet C (2011) The core Dravet syndrome phenotype. Epilepsia 52(Suppl 2):3\u20139. \n                        https:\/\/doi.org\/10.1111\/j.1528-1167.2011.02994.x","journal-title":"Epilepsia"},{"issue":"8","key":"427_CR8","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/j.1528-1167.2012.03511.x","volume":"53","author":"KC Epi","year":"2012","unstructured":"Epi KC (2012) Epi4K: gene discovery in 4,000 genomes. Epilepsia 53(8):1457\u20131467. \n                        https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03511.x","journal-title":"Epilepsia"},{"issue":"4","key":"427_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1227\/NEU.0000000000000875","volume":"77","author":"A Fallah","year":"2015","unstructured":"Fallah A, Rodgers SD, Weil AG et\u00a0al (2015) Resective epilepsy surgery for tuberous sclerosis in children: determining predictors of seizure outcomes in a\u00a0multicenter retrospective cohort study. Neurosurgery 77(4):517\u2013524. \n                        https:\/\/doi.org\/10.1227\/NEU.0000000000000875\n                        \n                     (discussion 524)","journal-title":"Neurosurgery"},{"issue":"1","key":"427_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5698\/1535-7597-16.1.46","volume":"16","author":"L Ferraro","year":"2016","unstructured":"Ferraro L, Pollard JR, Helbig I (2016) Attitudes toward epilepsy genetics testing among adult and pediatric epileptologists-results of a\u00a0Q-PULSE survey. Epilepsy Curr 16(1):46\u201347. \n                        https:\/\/doi.org\/10.5698\/1535-7597-16.1.46","journal-title":"Epilepsy Curr"},{"issue":"9861","key":"427_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S et al (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a\u00a0multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381(9861):125\u2013132. \n                        https:\/\/doi.org\/10.1016\/S0140-6736(12)61134-9","journal-title":"Lancet"},{"issue":"10056","key":"427_CR12","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a\u00a0phase 3, randomised, double-blind, placebo-controlled study. Lancet 388(10056):2153\u20132163. \n                        https:\/\/doi.org\/10.1016\/S0140-6736(16)31419-2","journal-title":"Lancet"},{"key":"427_CR13","volume-title":"GeneReviews(R)","author":"MF Hammer","year":"2016","unstructured":"Hammer MF, Wagnon JL, Mefford HC et al (2016) SCN8A-related epilepsy with encephalopathy. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K (Hrsg) GeneReviews(R). University of Washington, Seattle"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1212\/WNL.0000000000001926","volume":"85","author":"KB Howell","year":"2015","unstructured":"Howell KB, Mcmahon JM, Carvill GL et\u00a0al (2015) SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures. Neurology 85:958\u2013966. \n                        https:\/\/doi.org\/10.1212\/WNL.0000000000001926","journal-title":"Neurology"},{"issue":"5","key":"427_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejpn.2011.03.010","volume":"15","author":"S Jozwiak","year":"2011","unstructured":"Jozwiak S, Kotulska K, Domanska-Pakiela D et al (2011) Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol 15(5):424\u2013431. \n                        https:\/\/doi.org\/10.1016\/j.ejpn.2011.03.010","journal-title":"Eur J Paediatr Neurol"},{"issue":"11","key":"427_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamaneurol.2013.3090","volume":"70","author":"WG Leen","year":"2013","unstructured":"Leen WG, Wevers RA, Kamsteeg EJ et\u00a0al (2013) Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a\u00a0systematic review. JAMA Neurol 70(11):1440\u20131444. \n                        https:\/\/doi.org\/10.1001\/jamaneurol.2013.3090","journal-title":"JAMA Neurol"},{"issue":"9","key":"427_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.2728","volume":"45","author":"JR Lemke","year":"2013","unstructured":"Lemke JR, Lal D, Reinthaler EM et\u00a0al (2013) Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 45(9):1067\u20131072. \n                        https:\/\/doi.org\/10.1038\/ng.2728","journal-title":"Nat Genet"},{"issue":"01","key":"427_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1055\/s-0032-1307454","volume":"43","author":"J Lotte","year":"2012","unstructured":"Lotte J, Haberlandt E, Neubauer B et al (2012) Bromide in patients with SCN1A-mutations manifesting as Dravet syndrome. Neuropediatrics 43(01):17\u201321. \n                        https:\/\/doi.org\/10.1055\/s-0032-1307454","journal-title":"Neuropediatrics"},{"issue":"3","key":"427_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1474-4422(15)00250-1","volume":"15","author":"A Mctague","year":"2016","unstructured":"Mctague A, Howell KB, Cross JH et\u00a0al (2016) The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol 15(3):304\u2013316. \n                        https:\/\/doi.org\/10.1016\/S1474-4422(15)00250-1","journal-title":"Lancet Neurol"},{"issue":"12","key":"427_CR20","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1586\/14737159.2015.1113132","volume":"15","author":"RS Moller","year":"2015","unstructured":"Moller RS, Dahl HA, Helbig I (2015) The contribution of next generation sequencing to epilepsy genetics. Expert Rev Mol Diagn 15(12):1531\u20131538. \n                        https:\/\/doi.org\/10.1586\/14737159.2015.1113132","journal-title":"Expert Rev Mol Diagn"},{"issue":"11","key":"427_CR21","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1111\/epi.12810","volume":"55","author":"JO Okeke","year":"2014","unstructured":"Okeke JO, Tangel VE, Sorge ST et\u00a0al (2014) Genetic testing preferences in families containing multiple individuals with epilepsy. Epilepsia 55(11):1705\u20131713. \n                        https:\/\/doi.org\/10.1111\/epi.12810","journal-title":"Epilepsia"},{"issue":"3","key":"427_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/acn3.39","volume":"1","author":"TM Pierson","year":"2014","unstructured":"Pierson TM, Yuan H, Marsh ED et al (2014) GRIN2A mutation and early-onset epileptic encephalopathy: personalized therapy with memantine. Ann Clin Transl Neurol 1(3):190\u2013198. \n                        https:\/\/doi.org\/10.1002\/acn3.39","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"427_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1469-8749.2012.04406.x","volume":"55","author":"S Rahman","year":"2013","unstructured":"Rahman S, Footitt EJ, Varadkar S et\u00a0al (2013) Inborn errors of metabolism causing epilepsy. Dev Med Child Neurol 55(1):23\u201336. \n                        https:\/\/doi.org\/10.1111\/j.1469-8749.2012.04406.x","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"427_CR24","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jpeds.2008.05.012","volume":"153","author":"M Rauchenzauner","year":"2008","unstructured":"Rauchenzauner M, Klepper J, Leiendecker B et\u00a0al (2008) The ketogenic diet in children with Glut1 deficiency syndrome and epilepsy. J\u00a0Pediatr 153(5):716\u2013718. \n                        https:\/\/doi.org\/10.1016\/j.jpeds.2008.05.012","journal-title":"J Pediatr"},{"issue":"5","key":"427_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S et\u00a0al (2015) Standards and guidelines for the interpretation of sequence variants: a\u00a0joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. \n                        https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"427_CR26","volume-title":"AWMF Leitlinie: Therapie der Blitz-Nick-Salaam Epilepsie (West-Syndrom). AWMF","author":"BK Schmitt","year":"2014","unstructured":"Schmitt BK (2014) AWMF Leitlinie: Therapie der Blitz-Nick-Salaam Epilepsie\n\t\t\t\t\t\t(West-Syndrom). AWMF. \n                        http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/022-022k_S3_Blitz_Nick_Salaam_Epilespie_2014-10.pdf\n                        \n                    . Zugegriffen: 15.07.2017"},{"issue":"2","key":"427_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ene.13195","volume":"24","author":"A Schoonjans","year":"2017","unstructured":"Schoonjans A, Paelinck BP, Marchau F et al (2017) Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a\u00a0prospective study of a\u00a0new cohort of patients. Eur J Neurol 24(2):309\u2013314. \n                        https:\/\/doi.org\/10.1111\/ene.13195","journal-title":"Eur J Neurol"},{"key":"427_CR28","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/B978-0-444-59565-2.00053-8","volume":"113","author":"A Schulze","year":"2013","unstructured":"Schulze A (2013) Creatine deficiency syndromes. Handb Clin Neurol 113:1837\u20131843. \n                        https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00053-8","journal-title":"Handb Clin Neurol"},{"issue":"6","key":"427_CR29","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3171\/2015.5.PEDS14551","volume":"16","author":"KL Skjei","year":"2015","unstructured":"Skjei KL, Church EW, Harding BN et\u00a0al (2015) Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. J\u00a0Neurosurg Pediatr 16(6):668\u2013674. \n                        https:\/\/doi.org\/10.3171\/2015.5.PEDS14551","journal-title":"J Neurosurg Pediatr"},{"issue":"1","key":"427_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejpn.2012.07.006","volume":"17","author":"N Specchio","year":"2013","unstructured":"Specchio N, Terracciano A, Trivisano M et al (2013) PRRT2 is mutated in familial and non-familial benign infantile seizures. Eur J Paediatr Neurol 17(1):77\u201381. \n                        https:\/\/doi.org\/10.1016\/j.ejpn.2012.07.006","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"427_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/ng1095-201","volume":"11","author":"OK Steinlein","year":"1995","unstructured":"Steinlein OK, Mulley JC, Propping P et\u00a0al (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11(2):201\u2013203. \n                        https:\/\/doi.org\/10.1038\/ng1095-201","journal-title":"Nat Genet"},{"issue":"3","key":"427_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/ana.21724","volume":"66","author":"A Suls","year":"2009","unstructured":"Suls A, Mullen SA, Weber YG et al (2009) Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann Neurol 66(3):415\u2013419. \n                        https:\/\/doi.org\/10.1002\/ana.21724","journal-title":"Ann Neurol"},{"issue":"1","key":"427_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.celrep.2016.03.005","volume":"15","author":"P Valente","year":"2016","unstructured":"Valente P, Castroflorio E, Rossi P et al (2016) PRRT2 is a\u00a0key component of the ca(2+)-dependent neurotransmitter release machinery. Cell Rep 15(1):117\u2013131. \n                        https:\/\/doi.org\/10.1016\/j.celrep.2016.03.005","journal-title":"Cell Rep"},{"key":"427_CR34","volume-title":"Empfehlungen der Arbeitsgemeinschaft Genetik der Deutschen Gesellschaft f\u00fcr Epileptologie (DGfE)","author":"S Spiczak Von","year":"2017","unstructured":"Von Spiczak S, Weber Y (2017) Empfehlungen der Arbeitsgemeinschaft Genetik der Deutschen Gesellschaft f\u00fcr Epileptologie (DGfE)"},{"issue":"3","key":"427_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ejpn.2017.01.001","volume":"21","author":"C Stulpnagel Von","year":"2017","unstructured":"Von Stulpnagel C, Ensslen M, Moller RS et\u00a0al (2017) Epilepsy in patients with GRIN2A alterations: genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs. Eur J Paediatr Neurol 21(3):530\u2013541. \n                        https:\/\/doi.org\/10.1016\/j.ejpn.2017.01.001","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"427_CR36","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1172\/JCI34438","volume":"118","author":"YG Weber","year":"2008","unstructured":"Weber YG, Storch A, Wuttke TV et al (2008) GLUT1 mutations are a\u00a0cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a\u00a0cation leak. J\u00a0Clin Invest 118(6):2157\u20132168. \n                        https:\/\/doi.org\/10.1172\/JCI34438","journal-title":"J Clin Invest"},{"issue":"5","key":"427_CR37","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/brain\/awx054","volume":"140","author":"M Wolff","year":"2017","unstructured":"Wolff M, Johannesen KM, Hedrich UB et al (2017) Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain 140(5):1316\u20131366. \n                        https:\/\/doi.org\/10.1093\/brain\/awx054","journal-title":"Brain"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-017-0427-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0427-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-017-0427-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,4]],"date-time":"2017-12-04T08:07:18Z","timestamp":1512374838000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-017-0427-7"}},"subtitle":["Die Konsequenzen der Epilepsiegenetik","Therapeutic consequences of epilepsy genetics"],"short-title":[],"issued":{"date-parts":[[2017,9,20]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1007\/s00115-017-0427-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,20]]}}}